// App-Quantinova.ai

: Neutrophil gelatinase associated lipocalin (NGAL) as a theragnostic biomarker for perihilar cholangiocarcinoma

Researchers

Presenter

  • A. Nair

Principal Investigators

  • E.T. Verghese

  • N. Ingram

  • I. Wijetunga

  • A.F. Markham

  • J. Wyatt

  • K.R. Prasad

  • P.L. Coletta

Medical Centers

  • Leeds Institute of Biomedical & Clinical Sciences, UK

  • StJamess University Hospital, Leeds, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Advanced biliary tract carcinoma

Biomarkers

  • Lipocalin 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved